Sumitomo Mitsui Trust Group
MEDP icon

Sumitomo Mitsui Trust Group’s Medpace MEDP Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$519K Buy
+831
New +$487K ﹤0.01% 943
2026
Q2 		– Sell
-3,872
Closed -$1.86M – 1108
2026
Q1 		$1.86M Sell
3,872
-1,055
-21% -$540K ﹤0.01% 796
2025
Q4 		$2.77M Buy
4,927
+3,627
+279% +$2.06M ﹤0.01% 771
2025
Q3 		$668K Buy
+1,300
New +$568K ﹤0.01% 897
2024
Q3 		– Sell
-1,756
Closed -$723K – 1086
2024
Q2 		$723K Hold
1,756
– – ﹤0.01% 931
2024
Q1 		$710K Sell
1,756
-300
-15% -$105K ﹤0.01% 991
2023
Q4 		$630K Buy
2,056
+856
+71% +$231K ﹤0.01% 1023
2023
Q3 		$291K Buy
+1,200
New +$307K ﹤0.01% 1089

Other funds holding MEDP

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Riverbridge Partners
Riverbridge Partners Minneapolis, Minnesota $3.41B AUM 6.54% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Sumitomo Mitsui Trust Group's MEDP Position: Q3 2026 in Review

Sumitomo Mitsui Trust Group opened a new position in Medpace (MEDP) in Q3 2026: 831 shares worth $519K. The stake represents ﹤0.01% of the portfolio and ranks #943 among its holdings. This is a return to the name: Sumitomo Mitsui Trust Group previously reported a position in MEDP as recently as Q1 2026.

Sumitomo Mitsui Trust Group first reported a position in MEDP in Q3 2023 and has held it in 8 quarters since. The position peaked at $2.77M in Q4 2025. 369 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Sumitomo Mitsui Trust Group held 831 shares of Medpace worth $519K as of Q3 2026.
  • Medpace was a new Sumitomo Mitsui Trust Group position in Q3 2026.
  • Medpace made up ﹤0.01% of Sumitomo Mitsui Trust Group's portfolio in Q3 2026, its #943 holding.
  • Sumitomo Mitsui Trust Group first reported a position in Medpace in Q3 2023 and has held it in 8 quarters since.
  • Sumitomo Mitsui Trust Group's Medpace position peaked at $2.77M in Q4 2025.
  • 369 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2026, filed 29 Oct 2026.